The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...

Number 5: Leading biosimilar companies Sandoz, STADA Arzneimittel, and Samsung Bioepis report impressive Q1 2025 growth, ...

Leading biosimilar companies Sandoz, STADA Arzneimittel, and Samsung Bioepis report impressive Q1 2025 growth, driven by ...

German pharmaceutical firm Stada is in talks with two private equity investors about a sale, Germany's Welt newspaper reported on Tuesday. Its owners Bain Capital and Cinven could seek an initial ...

German drugmaker STADA Arzneimittel (SAZ: Xetra) has reported record earnings on revenues growth in its financial first quarter. Group adjusted, constant-currency (cc) revenues rose by 4% on an ...

BERLIN, June 3 (Reuters) - German pharmaceutical firm Stada is in talks with two private equity investors about a sale, Germany's Welt newspaper reported on Tuesday. Its owners Bain Capital and ...

Alvotech’s commercial partners include Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd. (US), STADA Arzneimittel AG (EU), Fuji Pharma Co., Ltd (Japan), Advanz Pharma ...

Assess the Stada Arzneimittel share price history. This page provides detailed historical share price data for STAGn, including daily, weekly, and monthly intervals of the opening price, closing price ...

Peter Goldschmidt became the CEO of pharmaceuticals company STADA in 2018. He was a firm believer in culture as a driving force – and a predictor – of organizational performance and competitiveness. A ...